Nivolumab
Nivolumab anti-PD-1) is a genetically engineered fully human immunoglobulin Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1PD-1PCD-1) with immune checkpoint inhibitory and antineoplastic activities.
Product Specifications
CAS Number
946414-94-4
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
146 kDa
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
PD-1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
244549-FITC 100 µL
CDKN2D (Cyclin-Dependent Kinase Inhibitor 2D (p19, inhibits CDK4), INK4D, p19, p19-INK4D) (FITC)
Sign In for Pricing
View Details 
MBS452436-01 48 Tests
Human Angiotensin I Converting Enzyme (ACE) ELISA Kit
Sign In for Pricing
View Details MBS452436-02 96 Tests
Human Angiotensin I Converting Enzyme (ACE) ELISA Kit
Sign In for Pricing
View Details MBS452436-03 5x 96 Tests
Human Angiotensin I Converting Enzyme (ACE) ELISA Kit
Sign In for Pricing
View Details